Page last updated: 2024-09-05

sorafenib and Viremia

sorafenib has been researched along with Viremia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, SC; Chuang, WL; Dai, CY; Hsieh, MH; Hsieh, MY; Huang, CF; Huang, CI; Huang, JF; Kuo, HT; Liang, PC; Lin, IH; Lin, ZY; Yeh, ML; Yu, ML1

Other Studies

1 other study(ies) available for sorafenib and Viremia

ArticleYear
Eradication of hepatitis C virus preserve liver function and prolong survival in advanced hepatocellular carcinoma patients with limited life expectancy.
    The Kaohsiung journal of medical sciences, 2021, Volume: 37, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Disease-Free Survival; Female; Hepacivirus; Humans; Life Expectancy; Liver; Liver Neoplasms; Male; Middle Aged; RNA, Viral; Sorafenib; Survival Analysis; Viremia

2021